Tanshinone IIA and tanshinone I suppress angiogenesis by targeting the protein kinase domains of VEGF/VEGFR2 and reducing the expression of VEGF in the human lung cancer cells (Tung et al., 2013; Xie et al., 2015). This evidence concerns the gene VEGFA and lung cancer.